FDA Approves Genetic Test for Patients With Breast Cancer
This is a discussion on FDA Approves Genetic Test for Patients With Breast Cancer within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; This novel genetic test, SPOT-Light HER2 CISH, should help predict the response of patients with breast cancer to trastuzumab ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
07-22-2008, 09:15 PM
|
|||
|
|||
FDA Approves Genetic Test for Patients With Breast Cancer
This novel genetic test, SPOT-Light HER2 CISH, should help predict the response of patients with breast cancer to trastuzumab treatment.
Medscape Medical News More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Pathologists Respond to Criticism After Breast Cancer Testing Errors | industry_news | Other Clinical Pharmacy News | 0 | 07-21-2008 10:51 AM |
| Lapatinib Appears Safe in Patients With Breast Cancer | industry_news | Other Clinical Pharmacy News | 0 | 07-17-2008 01:52 PM |
| Lapatinib Promising for Advanced ErbB2-Amplified Breast Cancer | industry_news | Other Clinical Pharmacy News | 0 | 07-09-2008 05:59 PM |
| Invitrogen gets breast cancer test approval | industry_news | Biotechnology News | 0 | 07-09-2008 05:59 PM |
| SPOTLIGHT: Pertuzumab slows breast cancer in study | industry_news | Biotechnology News | 0 | 06-01-2008 01:55 PM |
© 2008 DrugManagementForum™ powered by |
 |